ProCE Banner Activity

NSABP B-42 10-Yr Follow-up: Extended Adjuvant Letrozole After Previous Adjuvant AI Therapy in Postmenopausal Women With HR+ Breast Cancer

Slideset Download
Conference Coverage
In patients with HR+ early breast cancer, use of extended adjuvant letrozole after previous adjuvant AI therapy significantly improved disease-free survival with longer-term follow-up.

Released: December 19, 2019

Expiration: December 17, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Puma Biotechnology, Inc.

Seagen